Abstract
People with serious mental illnesses (SMIs) experience excess mortality, driven in large part by high rates of cardiovascular disease (CVD), with all cardiovascular disease risk factors elevated. Interventions designed to improve the cardiovascular health of people with SMI have been shown to lead to clinically significant improvements in clinical trials; however, the uptake of these interventions into real-life clinical settings remains limited. Implementation strategies, which constitute the “how to” component of changing healthcare practice, are critical to supporting the scale-up of evidence-based interventions that can improve the cardiovascular health of people with SMI. And yet, implementation strategies are often poorly described and rarely justified theoretically in the literature, limiting the ability of researchers and practitioners to tease apart why, what, how, and when implementation strategies lead to improvement. In this Perspective, we describe the implementation strategies that the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness is using to scale-up three evidenced-based interventions related to: (1) weight loss; (2) tobacco smoking cessation treatment; and (3) hypertension, dyslipidemia, and diabetes care for people with SMI. Building on concepts from the literature on complex health interventions, we focus on considerations related to the core function of an intervention (i.e., or basic purposes of the change process that the health intervention seeks to facilitate) vs. the form (i.e., implementation strategies or specific activities taken to carry out core functions that are customized to local contexts). By clearly delineating how implementation strategies are operationalized to support the interventions' core functions across these three studies, we aim to build and improve the future evidence base of how to adapt, implement, and evaluate interventions to improve the cardiovascular health of people with SMI.
Introduction
Cardiovascular disease (CVD) is the primary cause of preventable death for people with serious mental illnesses (SMIs) (1), due in large part to elevated rates of CVD risk factors (obesity, hypertension, dyslipidemia, and diabetes mellitus) and risk behaviors (tobacco smoking, physical inactivity, and unhealthy diet) that are 1.5–3 times higher in people with SMI than in the overall population (2–5). These disproportionately high rates are driven by a number of factors. At the patient level, metabolic side effects of psychotropic medications (6, 7) and shared pathophysiology between certain CVD and SMI conditions (e.g., altered inflammatory processes) (8, 9) can directly affect cardiovascular health; whereas socioeconomic risks, lack of social support, and cognitive impairment can contribute to suboptimal health habits and impede productive engagement with the healthcare system (10, 11). At the level of care delivery, the poor integration between general medical and specialty mental healthcare likely contributes to significant disparities in the levels of guideline-concordant care delivered to patients with SMI (12, 13). Primary care physicians may lack the comfort or experience in treating people with SMI, mental health specialists may view physical healthcare as outside their purview, and importantly, delivery systems often do not support or reimburse coordination efforts.
Fortunately, there are evidence-based interventions that can help improve the cardiovascular health of people with SMI. A growing number of behavioral interventions tailored to people with SMI have been shown in clinical trials to facilitate weight loss and tobacco smoking cessation (14–16). However, translating the improvements demonstrated in trials has been limited in real-life clinical settings, leading to the well-documented research-to-practice gap that undermines the uptake of many clinical interventions (17). In part, this is because implementation—or the process of gaining targeted organizational members' skillful, consistent, and committed use of a practice (18)—is often fraught with challenges, with roughly two-thirds of implementation efforts failing to achieve the intended result (19), and almost half having no effect on outcomes of interest (20). Implementation barriers are numerous and varied, including factors at the provider-level (e.g., providers' lack of self-efficacy to perform an evidence-based practice), organizational-level (e.g., lack of fit between the intervention and current workflows), and system-level (e.g., lack of policies and financing mechanisms that would support sustainable change).
To enhance the uptake of interventions, many translational projects employ implementation strategies, which refer to methods or techniques used to improve adoption, implementation, and sustainment of interventions (21). Implementation strategies constitute the “how to” component of changing healthcare practice (21) and range from discrete, relatively “light touch” strategies (e.g., reminder systems for clinicians) to more intensive multi-component strategies that may target multiple levels (e.g., organizational-level, provider-level, and consumer-level). The wide variation in implementation strategies is useful for addressing the diverse array of barriers that may affect implementation outcomes and long-term adoption. However, the tremendous variation, both in terms of the strategies themselves and the ways in which the strategies are described, have led some to characterize the literature on implementation as a ‘Tower of Babel” (22). Although several taxonomies have been developed to organize the types of strategies available (23, 24), implementation strategies are often poorly described in the literature and rarely justified theoretically. Given this lack of precision, implementation scholars are increasingly calling upon the research community to more clearly delineate how implementation strategies are operationalized (21, 25). With more robust specifications of who enacts the strategies and for what purpose, researchers and practitioners will be better able to tease apart why, what, how, and when implementation strategies actually lead to improvement.
In this paper, we describe the implementation strategies being leveraged by the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness, a research-practice translation center funded by the National Institute of Mental Health (NIMH) that aims to reduce premature mortality among people with SMI (26). The Center's goals are to develop and test implementation strategies to support the scale-up of three evidenced-based interventions related to: (1) weight loss; (2) tobacco smoking cessation treatment; and (3) hypertension, dyslipidemia, and diabetes care for people with SMI. Building on concepts from the literature on complex health interventions, we first consider the core functions, or basic purposes of the change process that the health intervention seeks to facilitate. We next describe the forms, or implementation strategies used to carry out the core functions, using Proctor et al.'s recommendations for specifying and reporting implementation strategies (21). By delineating how the selected implementation strategies have been operationalized to support the interventions' core functions across these three studies, we aim to inform and improve future efforts to adapt, implement, and evaluate interventions to improve the cardiovascular health of people with SMI.
Evidence-Based Interventions to Improve Cardiovascular Health
The Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness aims to develop and test multi-component implementation strategies to support the scale-up of three evidence-based interventions to reduce cardiovascular risk in SMI. The first project, named ACHIEVE-Dissemination (or ACHIEVE-D for short), is a 6-month evidence-based behavioral weight loss program tailored to adults with SMI that is being delivered in Psychiatric Rehabilitation Programs throughout Maryland. The intervention was adapted from the ACHIEVE randomized-controlled trial (RCT) (15, 27), in which participants who received the intervention (i.e., group and individual weight management sessions and group exercise classes primarily delivered by trained interventionists) experienced clinically significant weight loss (7 lbs. at 18 months). To promote scale-up of the intervention so that it could be implemented by mental health program staff, we adapted the ACHIEVE program using the Enhanced Replicating Effective Programs (REP) Framework (28) to increase the acceptability and feasibility of the ACHIEVE-D curriculum in community settings.
The second project, IMPACT, is a 12-month intervention to support the uptake of evidence-based tobacco smoking cessation treatment (14, 29) in community mental health clinics in Maryland. The overarching premise is that clinics should implement the following evidence-based practices: (1) screening for tobacco use in all patients, (2) assessment of willingness to quit for those who smoke, (3) behavioral counseling for those interested in cutting down or quitting smoking, and (4) pharmacotherapy for those interested in cutting down or quitting smoking. The IMPACT intervention is designed for community mental health organization leaders and providers (e.g., therapists including licensed social workers, counselors, and psychologists; and physician, nurse practitioner, and physician assistant prescribers) to deliver the program to patients who attend community mental health clinics and currently smoke tobacco. To increase mental health providers' uptake of the intervention, we are using Gurses et al.'s interdisciplinary framework of clinicians' compliance with evidence-based guidelines (30) to guide our assessment of baseline characteristics of the clinics, providers, and evidence-based practice as well as relevant mechanisms of change (i.e., providers' knowledge and self-efficacy) to be targeted by implementation efforts.
The third project, RHYTHM, is a 12-month care coordination intervention that aims to equip mental health providers with the ability to coordinate guideline-concordant care for hypertension, dyslipidemia, and diabetes mellitus among people with SMI in the context of Psychiatric Rehabilitation Programs implementing behavioral health homes in Maryland (31–33). Guided by the Translating Evidence into Practice (TRIP) model for large-scale knowledge translation into community settings (34), the study team conducted a comprehensive review of clinical guidelines and scholarly literature to create a bundle of evidence-based care processes for hypertension, dyslipidemia, and diabetes tailored for people with SMI. The bundle includes two overarching components: (1) clinical care processes (e.g., annual dilated eye exam for patients with diabetes), and (2) care coordination and management processes (e.g., using a brief form to facilitate communication between a primary care provider and behavioral health home team at the time of a routinely scheduled visit). These evidence-based practices will be implemented using an adapted version of the Comprehensive Unit Safety Program (CUSP) strategy, which seeks to foster a team-based quality improvement culture and reduce preventable harm (31).
Form vs. Function
These three evidence-based interventions to improve cardiovascular health for people with SMI can be thought of as complex health interventions in which (1) the intervention's multiple components interact in a summative and synergistic fashion; (2) individuals delivering and receiving the intervention exhibit a highly complex set of behaviors; (3) changes are required at multiple levels (e.g., organizational, workforce, or patient); (4) outcomes are numerous and variable; and (5) there is some flexibility in how the intervention is implemented (35). Within the literature on complex health interventions, there is a useful distinction between the core functions of an intervention, which speaks to the basic purposes of the change process that the health intervention seeks to facilitate; and its forms, which speaks to specific strategies or activities that may be customized to local context and that are needed to carry out the core functions (36). With regards to an intervention's core functions, it is important to note that the “basic purposes of the change process” applies to both the clinical/therapeutic/administrative changes associated with improving health outcomes for patients (e.g., reducing consumption of sugar-sweetened beverages in people with SMI) as well as the implementation-related changes associated with putting the clinical or behavioral intervention into practice (e.g., training providers to increase their knowledge of an intervention). In this Perspective, we focus on the core functions of the implementation-related changes and how these map on to the specific forms, or implementation strategies, designed to facilitate these changes.
Core Functions of the Interventions
All three of the Center's projects share certain core functions related to putting the clinical interventions into practice (Table 1). For example, a core function that supports the delivery of guideline-concordant care across all three projects is to create written processes and defined standards including manuals for delivering care. Moreover, since all of the interventions are being implemented by mental health program staff—not research staff—another core function is to educate clinicians and staff to be able to deliver the interventions' components with fidelity and to use skills in motivational interviewing (i.e., an evidence-based and patient-centered communication method) to more effectively engage with clients in conversations around the targeted behaviors. To complement this educational component, a third core function is to provide opportunities to practice the motivational interviewing techniques that mental health program staff are introduced to through training. All of the projects also aim to facilitate a supportive implementation climate at the organizational-level in which mental health program staff perceive that the adoption, implementation, and use of an innovation is expected, rewarded, and supported by the organization (37).
Table 1
| Intervention | Core Functions | Forms (implementation strategies) |
|---|---|---|
| All ALACRITY center projects | Create written processes, defined standards, and manuals for delivering guideline-concordant care | Protocol |
| Educate clinicians and staff to deliver the intervention | Training | |
| Provide opportunity to practice motivational interviewing skills when discussing the targeted behavior | Avatar practice modules | |
| Facilitate a supportive implementation climate for change | Organizational strategy meetings, adapted comprehensive unit safety program (CUSP) | |
| Setting-specific | ||
| ACHIEVE-D: 6-month tailored behavioral weight loss intervention delivered by psychiatric rehabilitation program (PRP) staff | Provide tailored feedback to staff on their delivery of the intervention (in the enhanced arm) | Performance coaching |
| IMPACT: 12-month evidence-based tobacco smoking cessation treatment delivered by community mental health clinic prescribers and therapists | Provide clinical consultation and support | Coaching |
| Expert consultation | ||
| RHYTHM: 12-month care coordination intervention for hypertension, dyslipidemia, and diabetes mellitus delivered by behavioral health home providers and PRP staff | Foster a team-based quality improvement culture | Adapted comprehensive unit safety program (CUSP) |
Overview of the interventions' core functions and forms.
Several of the core functions are also specific to the design of a particular intervention. In ACHIEVE-D, for example, mental health program staff serve as “coaches” to deliver weight management and exercise sessions. Consequently, a core function specific to this intervention that will be tested in the “enhanced condition” of the project is to provide tailored feedback to coaches on their delivery of these sessions. In IMPACT, in which therapists and prescribers are responsible for delivering smoking cessation treatment, a core function is to provide clinical consultation and support related to behavioral counseling for smoking cessation and prescription of pharmacotherapy. Lastly, for RHYTHM, which seeks to improve care coordination processes, one of this project's core functions is to foster a team-based quality improvement culture where providers work together to identify a patient-centered problem and then address barriers to receipt of evidence-based care for that problem.
Specifying Implementation Strategies
Whereas the core functions help to clarify the basic purposes of the change process, the corresponding forms—or implementation strategies—illustrate the specific activities that are needed to carry out the core functions and that can be customized to a local context.
In order to describe how implementation strategies have been operationalized with enough detail to enable measurement and reproducibility, Proctor et al. (21) recommends that researchers specify the: (1) actor(s), (2) action(s), (3) action target(s), (4) temporality, (5) dose, (6) implementation outcomes affected, and (7) theoretical, empirical, or pragmatic justification. The actor is defined as the stakeholder who actually delivers the implementation strategy, which for all three Center projects includes faculty and intervention experts from the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness. The actions indicate the actions, steps or processes, and sequences of behavior (e.g., provide clinical supervision), whereas action targets refer to conceptual targets they attempt to impact (e.g., knowledge about the evidence-based practice). Temporality refers to the stage or phase when the strategy is used, dose refers to the dosage or intensity of the strategy, and implementation outcomes typically refer to Proctor et al.'s (38) taxonomy of implementation outcomes (acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, penetration, and sustainability). Last, the justification includes the rationale for why a strategy is being used.
For the Center's three interventions, the core functions of the changes process that are shared across projects also have corresponding implementation strategies in common, although the strategies vary in terms of how they are being operationalized (Table 2). For example, in order to support the core function of educating clinicians and staff to deliver the intervention, all of the projects include synchronous training that is delivered virtually in real-time as an implementation strategy. However, the dose of the training ranges from 2 h (for prescribers in IMPACT) to 15 h (for coaches in ACHIEVE-D), reflecting both the amount of content that needs to be covered as well as the feasibility of conducting the targeted actions.
Table 2
| All ALACRITY center projects | ||||||
|---|---|---|---|---|---|---|
| Implementation strategy | Action | Action targets | Temporality | Dose | Outcome | |
| Treatment protocol | Provide a manual for delivering the evidence-based practices | Knowledge and self-efficacy of coaches/peer leaders (ACHIEVE-D), therapists/prescribers (IMPACT), and clinic staff (RHYTHM) to deliver the intervention | Ongoing | As needed | Adoption, fidelity | |
| Synchronous online training | Present information needed to implement all intervention components including brief training on motivational interviewing (MI); provide opportunity to practice skills | Knowledge, self-efficacy, and skills of coaches/peer leaders (ACHIEVE-D), therapists/prescribers (IMPACT), and clinic staff (RHYTHM) to deliver the intervention | Pre- implementation | ACHIEVE-D: (15 h) IMPACT: (4 h)/for therapists; (2 h)/for prescribers RHYTHM: (12 h) | Adoption, fidelity | |
| Avatar practice modules | Provide opportunity to practice motivational interviewing techniques for targeted behaviors | Self-efficacy of coaches (ACHIEVE-D), therapists/prescribers (IMPACT), and clinic staff (RHYTHM) in using motivational interviewing techniques | Monthly | ACHIEVE-D: (20 min) IMPACT: (15 min) RHYTHM: (15 min) | Penetration amongst clients, fidelity to the MI method | |
| Setting specific | ||||||
| ACHIEVE-D | Performance coaching (for the enhanced arm of the project) | Provide tailored feedback to coaches regarding their delivery of video-taped group sessions | Coaches' ability to deliver group sessions with fidelity to the curriculum; motivational interviewing skill development | Monthly | 1 h | Penetration amongst clients, fidelity to the intervention |
| Asynchronous online training | Review key concepts and discussion points prior to delivering the module; complete learning activity and quiz for each online training module | Coaches and peer leaders' knowledge, self-efficacy, and skills to deliver upcoming group sessions | Monthly | 20 min | Penetration amongst clients Fidelity to the intervention | |
| Organizational strategy meetings | Provide data feedback on client attendance at group sessions; identify barriers at the individual and organizational levels; support group problem-solving; support learning within teams | Implementation climate and leadership engagement at the organizational level | Monthly | 30 min | Adoption, Penetration amongst clients, fidelity to the intervention | |
| IMPACT | Asynchronous online training | Present introductory information on core components of IMPACT | Therapists and prescribers' knowledge of the intervention | Pre-implementation | Once (1 h) | Adoption |
| Coaching calls | Provide clinical consultation and support for behavioral counseling or pharmacotherapy | Therapists and prescribers' knowledge, skills, and access to expertise | Monthly | (30 min)/therapists (15 min)/prescribers | Fidelity to the intervention | |
| Expert consultation | Provide support for behavioral counseling or pharmacotherapy | Prescribers and therapists' knowledge and skills, and access to expertise | Ongoing | As needed | Fidelity to the intervention | |
| Organizational strategy meetings | Provide data feedback on delivery of core components; identify barriers at the organizational level; support group problem-solving | Implementation climate and leadership engagement at the organizational level | Monthly | 30 min | Adoption, Penetration amongst clients, Fidelity to the intervention | |
| RHYTHM | Adapted comprehen-sive unit safety program (CUSP) | Identify barriers, plan strategies to remove barriers, study and refine strategy; support learning within teams; support team members | Clinic staff members' knowledge, self-efficacy, skills, and access to internal expertise; remove barriers; promote supportive organizational climate for RHYTHM | Monthly | 2–3 h | Acceptability, Adoption, Feasibility, Fidelity to the intervention, Penetration amongst clients |
Specification of implementation strategies.
Actors: All actions performed by faculty and intervention experts from the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness.
Theoretical justification: ACHIEVE-D: Enhanced Replicating Effective Programs (REP) Model; IMPACT: Gurses et al.'s interdisciplinary framework of clinicians' compliance with evidence-based guidelines; RHYTHM: Translating Evidence into Practice (TRIP) model.
To meet the needs of the core functions of the change process that are intervention-specific, the Center is also employing an array of implementation strategies that are particular to each project. For example, to enable a culture of quality improvement at participating sites, the RHYTHM project is leveraging an adapted Comprehensive Unit Safety Program (CUSP) implementation strategy comprised of provider training (which is a discrete strategy common across projects) that is combined with expert facilitation and implementation of a five-step quality improvement process (which are strategies specific to RHYTHM). The CUSP strategy is designed to foster a team-based quality improvement culture, in which clinicians and staff are first trained on the science of quality improvement, and then work in CUSP teams to create a process at their organization for continuously identifying and addressing barriers to evidence-based care. By training providers and putting standard processes to implement evidence-based care in place, the CUSP implementation strategy is designed to improve the organization's culture as well as providers' self-efficacy to deliver guideline-concordant care.
Discussion
Improving the cardiovascular health of people with SMI is a lynchpin to reducing premature mortality in this population. To effectively scale-up interventions that have demonstrated significant improvements in CVD risks and risk behaviors in clinical trial settings, it is imperative to use implementation strategies that speak to both the core functions of the intervention's change processes and the localized implementation context. In this Perspective, we describe how the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness is operationalizing implementation strategies to support the core functions of three evidence-based interventions related to weight loss (ACHIEVE-D); tobacco smoking cessation treatment (IMPACT); and hypertension, dyslipidemia, and diabetes mellitus care (RHYTHM) for people with SMI which, in total, address all cardiovascular risk factors. By clearly specifying how the implementation strategies have been operationalized, our goal is to contribute to the evidence base of why, how, and when implementation strategies can lead to supporting successful uptake of interventions, and ultimately, improved patient outcomes.
Moving forward, it will be important to consider how implementation strategies are being adapted to increase their acceptability and feasibility in real-life clinical settings, including modifications to improve their fit with local populations, settings, and contexts. The need to account for such adaptations is particularly salient amidst the backdrop of the COVID-19 pandemic, in which the turbulence of the external environment has prompted the need for significant modifications. For example, for all three of the Center's projects, training for mental health program staff was originally designed to be delivered in-person. With the onset of the pandemic, and ensuing restrictions related to in-person gatherings, the Center's faculty and intervention experts had to quickly pivot to reformat the training for the virtual environment. In order to systematically capture these adaptations, the Center plans to use the FRAME-IS model (39), a comprehensive framework for documenting modifications to implementation strategies, in an effort to specify implementation strategies not just in their intended form, but also in the ways in which they have evolved to respond to localized needs. Moreover, as the effectiveness of implementation strategies will likely vary (40), we plan to measure the fidelity with which the strategies are enacted so that we can better ascertain whether the strategies' effectiveness (or relative lack thereof) can be attributed to the strategy itself or to other contextual factors.
The ALACRITY Center projects are pilot in scope, and are designed to provide a foundation to inform future scale-up of evidence-based interventions to decrease cardiovascular risk in persons with SMI. Future work should incorporate hybrid implemementation effectiveness trials testing how these strategies can support intervention implementation on a larger scale. In addition, the implementation strategies used in the Center's current projects are largely focused on supporting change at the provider- or patient-level. In order to achieve widespread scale-up, an important next step will be to consider how to integrate these strategies with system-level and policy strategies at multiple levels (e.g., governmental, payer, system, and organizational). For example, it will be critical to consider what reimbursement mechanisms or other funding streams would be most appropriate and feasible to incentivize uptake of the evidence-based interventions in community settings. The ALACRITY Center's planned future work will include this policy and system-level focus with the goal to accelerate nationwide scale-up of evidence-based interventions addressing cardiovascular risk, and ultimately, reduce premature mortality in people with SMI.
Funding
The authors gratefully acknowledge support from the National Institute of Mental Health (NIMH) Grant P50MH11584201.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
CY, EEM, SG, AD, FD, KG, GJ, DT, KM, and GD contributed to the conception and design of the study. CY, EEM, SG, EM, and GD drafted the manuscript and all authors assisted with critically reviewing and revising the manuscript for important intellectual content. EEM and GD were responsible for obtaining funding for the study. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
CorrellCUSolmiMVeroneseNBortolatoBRossonSSantonastasoPet al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. (2017) 16:163–80. 10.1002/wps.20420
2.
NewcomerJWHennekensCH. Severe mental illness and risk of cardiovascular disease. JAMA. (2007) 298:1794–6. 10.1001/jama.298.15.1794
3.
CookBLWayneGFKafaliENLiuZShuCFloresM. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. (2014) 311:172–82. 10.1001/jama.2013.284985
4.
CasagrandeSSAndersonCADalcinAAppelLJJeromeGJDickersonFBet al. Dietary intake of adults with serious mental illness. Psychiatr Rehabil J. (2011) 35:137–40. 10.2975/35.2.2011.137.140
5.
JohnstoneRNicolKDonaghyMLawrieS. Barriers to uptake of physical activity in community-based patients with schizophrenia. J Mental Health. (2009) 18:523–32. 10.3109/09638230903111114
6.
McIntyreRSMcCannSMKennedySH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry. (2001) 46:273–81. 10.1177/070674370104600308
7.
McGintyEEDaumitGL. Epidemiology of obesity. Psychiatr Ann. (2011) 41:484–8. 10.3928/00485713-20110921-07
8.
KucukgoncuSKosirUZhouESullivanESrihariVHTekC. Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: a systematic review and meta-analysis. Early Interv Psychiatry. (2019) 13:1021–31. 10.1111/eip.12749
9.
CalkinCVGardnerDMRansomTAldaM. The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann Med. (2013) 45:171–81. 10.3109/07853890.2012.687835
10.
DraineJSalzerMSCulhaneDPHadleyTR. Role of social disadvantage in crime, joblessness, and homelessness among persons with serious mental illness. Psychiatr Serv. (2002) 53:565–73. 10.1176/appi.ps.53.5.565
11.
GreenMF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry. (2006) 67:36–42. 10.4088/JCP.1006e12
12.
DrussBG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. (2007) 68:40. 10.4088/JCP.0407e09
13.
McGintyEEBallerJAzrinSTJuliano-BultDDaumitGL. Quality of medical care for persons with serious mental illness: a comprehensive review. Schizophr Res. (2015) 165:227–35. 10.1016/j.schres.2015.04.010
14.
EvinsAECatherCPrattSAPachasGNHoeppnerSSGoffDCet al. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA. (2014) 311:145–54. 10.1001/jama.2013.285113
15.
DaumitGLDickersonFBWangN-YDalcinAJeromeGJAndersonCAet al. A behavioral weight-loss intervention in persons with serious mental illness. New Engl J Med. (2013) 368:1594–602. 10.1056/NEJMoa1214530
16.
GreenCAYarboroughBJHLeoMCYarboroughMTStumboSPJanoffSLet al. The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry. (2015) 172:71–81. 10.1176/appi.ajp.2014.14020173
17.
CurranGMBauerMMittmanBPyneJMStetlerC. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. (2012) 50:217–26. 10.1097/MLR.0b013e3182408812
18.
KleinKJSorraJS. The challenge of innovation implementation. Acad Manag Rev. (1996) 21:1055–80. 10.5465/amr.1996.9704071863
19.
DamschroderLJAronDCKeithREKirshSRAlexanderJALoweryJC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. (2009) 4:50. 10.1186/1748-5908-4-50
20.
PowellBJProctorEKGlassJE. A systematic review of strategies for implementing empirically supported mental health interventions. Res Soc Work Pract. (2014) 24:192–212. 10.1177/1049731513505778
21.
ProctorEKPowellBJMcMillenJC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. (2013) 8:1–11. 10.1186/1748-5908-8-139
22.
McKibbonKALokkerCWilczynskiNLCiliskaDDobbinsMDavisDAet al. A cross-sectional study of the number and frequency of terms used to refer to knowledge translation in a body of health literature in 2006: a Tower of Babel?Implement Sci. (2010) 5:1–11. 10.1186/1748-5908-5-16
23.
PowellBJWaltzTJChinmanMJDamschroderLJSmithJLMatthieuMMet al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. (2015) 10:1–14. 10.1186/s13012-015-0209-1
24.
LeemanJBaernholdtMSandelowskiM. Developing a theory-based taxonomy of methods for implementing change in practice. J Adv Nurs. (2007) 58:191–200. 10.1111/j.1365-2648.2006.04207.x
25.
LeemanJBirkenSAPowellBJRohwederCSheaCM. Beyond “implementation strategies”: classifying the full range of strategies used in implementation science and practice. Implement Sci. (2017) 12:1–9. 10.1186/s13012-017-0657-x
26.
McGintyEEMurphyKADalcinATStuartEAWangN-YDickersonFet al. A model for advancing scale-up of complex interventions for vulnerable populations: the ALACRITY center for health and longevity in mental illness. J Gen Intern Med. (2021) 36:500–5. 10.1007/s11606-020-06137-x
27.
CasagrandeSSJeromeGJDalcinATDickersonFBAndersonCAAppelLJet al. Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trial. BMC Psychiatry. (2010) 10:1–12. 10.1186/1471-244X-10-108
28.
KilbourneAMNeumannMSPincusHABauerMSStallR. Implementing evidence-based interventions in health care: application of the replicating effective programs framework. Implement Sci. (2007) 2:1–10. 10.1186/1748-5908-2-42
29.
CatherCPachasGNCieslakKMEvinsAE. Achieving smoking cessation in individuals with schizophrenia: special considerations. CNS Drugs. (2017) 31:471–81. 10.1007/s40263-017-0438-8
30.
GursesAPMarstellerJAOzokAAXiaoYOwensSPronovostPJ. Using an interdisciplinary approach to identify factors that affect clinicians' compliance with evidence-based guidelines. Crit Care Med. (2010) 38:S282–S91. 10.1097/CCM.0b013e3181e69e02
31.
McGintyEEThompsonDMurphyKAStuartEAWangN-YDalcinAet al. Adapting the Comprehensive Unit Safety Program (CUSP) implementation strategy to increase delivery of evidence-based cardiovascular risk factor care in community mental health organizations: protocol for a pilot study. Implement Sci Commun. (2021) 2:1–12. 10.1186/s43058-021-00129-6
32.
DaumitGLDalcinATDickersonFBMillerEREvinsAECatherCet al. Effect of a comprehensive cardiovascular risk reduction intervention in persons with serious mental illness: a randomized clinical trial. JAMA Network Open. (2020) 3:e207247. 10.1001/jamanetworkopen.2020.7247
33.
DrussBGvon EsenweinSAGlickGEDeublerELallyCWardMCet al. Randomized trial of an integrated behavioral health home: the health outcomes management and evaluation (HOME) study. Am J Psychiatry. (2017) 174:246–55. 10.1176/appi.ajp.2016.16050507
34.
PronovostPJBerenholtzSMNeedhamDM. Translating evidence into practice: a model for large scale knowledge translation. BMJ. (2008) 337:a1714. 10.1136/bmj.a1714
35.
CraigPDieppePMacintyreSMichieSNazarethIPetticrewM. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. (2008) 337:a1655. 10.1136/bmj.a1655
36.
HawePShiellARileyT. Complex interventions: how “out of control” can a randomised controlled trial be?BMJ. (2004) 328:1561–3. 10.1136/bmj.328.7455.1561
37.
WeinerBJBeldenCMBergmireDMJohnstonM. The meaning and measurement of implementation climate. Implement Sci. (2011) 6:1–12. 10.1186/1748-5908-6-78
38.
ProctorESilmereHRaghavanRet al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. (2011) 38, 65–76. 10.1007/s10488-010-0319-7
39.
MillerCJBarnettMLBaumannAAGutnerCAWiltsey-StirmanS. The FRAME-IS: a framework for documenting modifications to implementation strategies in healthcare. Implement Sci. (2021) 16:1–12. 10.1186/s13012-021-01105-3
40.
LewisCCKlasnjaPPowellBJLyonARTuzzioLJonesSet al. From classification to causality: advancing understanding of mechanisms of change in implementation science. Front Public Health. (2018) 6:e00136. 10.3389/fpubh.2018.00136
Summary
Keywords
implementation strategies, scale-up, serious mental illness, cardiovascular health, evidence-based interventions, implementation
Citation
Yuan CT, McGinty EE, Dalcin A, Goldsholl S, Dickerson F, Gudzune KA, Jerome GJ, Thompson DA, Murphy KA, Minahan E and Daumit GL (2022) Scaling Evidence-Based Interventions to Improve the Cardiovascular Health of People With Serious Mental Illness. Front. Psychiatry 13:793146. doi: 10.3389/fpsyt.2022.793146
Received
11 October 2021
Accepted
11 January 2022
Published
04 February 2022
Volume
13 - 2022
Edited by
Andrea Fiorillo, University of Campania Luigi Vanvitelli, Italy
Reviewed by
Giulia Menculini, University of Perugia, Italy; Carmen Moret-Tatay, Catholic University of Valencia San Vicente Mártir, Spain; Gaia Sampogna, University of Campania “L. Vanvitelli”, Italy
Updates
Copyright
© 2022 Yuan, McGinty, Dalcin, Goldsholl, Dickerson, Gudzune, Jerome, Thompson, Murphy, Minahan and Daumit.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Christina T. Yuan cyuan16@jhu.edu
This article was submitted to Psychosomatic Medicine, a section of the journal Frontiers in Psychiatry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.